Eli Lilly and Company has decided that it will not abide by the statutory requirements of the PACE Program’s manufacturer’s rebate mandate.
Accordingly, effective Monday, June 13, 2005, the Commonwealth will no longer be able to reimburse for any Eli Lilly products for PACE, PACENET, CRDP, SPBP, Cystic Fibrosis, Spina Bifida, PKU or MSUD.
Questions concerning this action may be directed to:
Senior Vice President, Corporate Strategy and Policy
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
With PACE no longer permitted to reimburse for Lilly pharmaceuticals, concerned prescribers, providers or caregivers of cardholders in need of Lilly products are encouraged to contact LillyAnswers, a patient assistance program for low-income individuals. Applications can be obtained by calling 1-877-795-4559 (toll-free) or visiting their website at www.lillyanswers.com/ .